ABN Amro Investment Solutions Purchases Shares of 34,823 Healthpeak Properties, Inc. $DOC

ABN Amro Investment Solutions purchased a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) during the 4th quarter, HoldingsChannel reports. The firm purchased 34,823 shares of the real estate investment trust’s stock, valued at approximately $560,000.

Several other large investors have also added to or reduced their stakes in DOC. State Street Corp grew its position in Healthpeak Properties by 1.8% during the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after purchasing an additional 895,460 shares during the period. JPMorgan Chase & Co. grew its position in Healthpeak Properties by 41.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock worth $540,730,000 after purchasing an additional 8,212,504 shares during the period. Cullen Capital Management LLC grew its position in Healthpeak Properties by 6.7% during the 3rd quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock worth $195,960,000 after purchasing an additional 641,771 shares during the period. Dimensional Fund Advisors LP grew its position in Healthpeak Properties by 4.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 10,228,560 shares of the real estate investment trust’s stock worth $195,873,000 after purchasing an additional 400,900 shares during the period. Finally, Bank of America Corp DE grew its position in Healthpeak Properties by 28.5% during the 3rd quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock worth $190,292,000 after purchasing an additional 2,206,222 shares during the period. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Analyst Upgrades and Downgrades

DOC has been the topic of several analyst reports. Argus downgraded Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd. UBS Group increased their price target on Healthpeak Properties from $17.00 to $19.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 13th. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Finally, Evercore downgraded Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target on the stock. in a research report on Monday, May 11th. Five research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $19.08.

Insider Activity at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider directly owned 7,636 shares in the company, valued at $148,520.20. This trade represents a 59.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.23% of the stock is owned by company insiders.

Healthpeak Properties Price Performance

NYSE:DOC opened at $19.74 on Monday. Healthpeak Properties, Inc. has a 52 week low of $15.70 and a 52 week high of $19.91. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a market capitalization of $13.61 billion, a PE ratio of 61.68, a price-to-earnings-growth ratio of 2.51 and a beta of 1.00. The stock’s 50-day moving average price is $17.49 and its 200-day moving average price is $17.26.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm had revenue of $752.95 million for the quarter, compared to analysts’ expectations of $694.59 million. During the same period last year, the firm earned $0.46 EPS. The company’s quarterly revenue was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, equities analysts expect that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be given a dividend of $0.1017 per share. The ex-dividend date is Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 6.2%. Healthpeak Properties’s dividend payout ratio (DPR) is 381.25%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.